- theory and concepts
- decision psychology
- probability/bayes
- preferences/values
- priority setting/ethics
- evidence synthesis
- calibration/validation
- approaches and applications
- decision analysis
- risk analysis
- benefit-cost analysis
- cost-effectiveness analysis
- technology assessment
- operations research
- health systems
- economics/finance
- middle east & north africa
- europe
- asia & pacific
Resources Repository
-
OrganizationWeb Portal 2024Institute for Clinical and Economic Review (ICER)
ICER is a non-profit organization that evaluates evidence on a range of topics including the value …
ICER is a non-profit organization that evaluates evidence on a range of topics including the value of medical tests, treatments and delivery system innovations and moves that evidence into action to improve the health care system. To accomplish this goal ICER performs analyses on effectiveness and costs, supports specific programs, and develops reports using innovative methods that make it easier to translate evidence into decisions that can align efforts to use evidence to drive improvements in both…
Evidence Synthesis | Priority Setting/Ethics | Preferences/Values | Technology Assessment | Cost-Effectiveness Analysis | Economics/Finance | Europe | Health Systems | Value of Information | Infectious Diseases | Chronic Disease/Risk | Mental Health | Business/Industry | Government/Law | Health/Medicine | Science/Technology | North America -
GuidelinesPublication 2013Economic Analyses to Support Decisions about HPV Vaccination in Low- and Middle-Income Countries: Consensus Report and Guide
Low- and middle-income countries need to consider economic issues such as cost-effectiveness, affordability and sustainability …
Low- and middle-income countries need to consider economic issues such as cost-effectiveness, affordability and sustainability before introducing a program for human papillomavirus (HPV) vaccination. However, many such countries lack the technical capacity and data to conduct their own analyses. This report describes the consensus of an expert group convened by the World Health Organization, prioritizing key issues to be addressed when considering economic analyses to support HPV vaccine introduction in these countries. The expert group…
Cost-Effectiveness Analysis | Economics/Finance | Asia & Pacific | Middle East & North Africa | Health Systems | Costing Methods | Health Outcomes | Infectious Diseases | Chronic Disease/Risk | Health/Medicine | Science/Technology | Sub-Saharan Africa | Latin America & Caribbean